HLA-DRB5 and non-small cell lung carcinoma: This study is the first to propose that the HLA-DRB5 gene in NSCLC tumor cells may inhibit the occurrence of STAS, and NSTAS samples showing high HLA-DRB5 expression potentially indicate higher immune cell infiltration and an anti-immune response.